How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...

Sun Pharmaceutical Industries slipped 4.30% to 1,778.85 after the US District Court of New Jersey has decided to grant a preliminary injunction delaying the launch of Leqselvi (Baldness treatment) in ...

In the worst-case scenario, an unfavourable judgment would prevent Sun Pharma from launching Leqselvi until the patent expires, delaying its market entry.

Shares of Sun Pharmaceutical fell 2.64 per cent after the pharma major recently announced that the US District Court of ...

Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.18% to 1,849.05 Indian rupees Thursday, on what proved to be an all-around rough trading session for the stock market, with the ...

Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in New Jersey has issued a preliminary injunction.

Despite this setback, Sun Pharma’s stock has rallied 43 per cent year-to-date, fueled by growth in speciality drugs, emerging ...

Sun Pharma revenue came in-line with our estimates (-1.0%) whereas EBITDA was largely in-line with our estimate (-2.1%) and Adj. PAT missed our estimate due to higher-than-expected finance costs ...

Mumbai: Indoco Remedies has announced the appointment of Vaibhav Sinha as Senior Management Personnel designated as Vice ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Nifty 50 and Sensex were trading flat at pre–open. Sun Pharmaceutical Industries Ltd., and Zomato Ltd. may move in Monday ...